Cancer News and Research

Latest Cancer News and Research

New study reviews science behind the efficacy of biofield therapies on pain management

Biofield therapies, which claim to use subtle energy to stimulate the body's healing process, are promising complementary interventions for reducing the intensity of pain in a number of conditions, reducing anxiety for hospitalized patients and reducing agitated behaviors in dementia, over and above what standard treatments can achieve.

30 Oct 2009

Hard to Treat Diseases negotiating possible merger with EU based stem cell research company

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.

30 Oct 2009

University of Virginia Cancer Center commences patient treatment with the TomoDirect delivery mode

TomoTherapy Incorporated announced today that the first patients are now being treated with the TomoDirect™ radiation therapy delivery mode at the University of Virginia Cancer Center. The addition of the TomoDirect modality to the TomoTherapy® platform gives clinicians an efficient new option that expands their ability to fight cancer.

30 Oct 2009

Heidelberg Ion Radiation Therapy Center established; European patients can benefit from new radiation therapy

A new, innovative form of radiation based on verified scientific facts will be available to patients all over Europe within the next few decades. The official kick-off meeting of the Community project ULICE (Union of LIght Ions Centres in Europe), which the European Union is supporting with nearly 10 million euros, was held in fall 2009 in the Department of Radiooncology and Radiation Therapy of the Heidelberg University Hospital.

30 Oct 2009

NIH awards $75 million to establish medical research consortium to combat health disparities

The National Institutes of Health has awarded $75 million to Charles Drew University of Medicine and Science and three other historically black institutions to establish a medical research consortium to combat health disparities in minority and underserved populations.

30 Oct 2009

TGen to secure emergency FDA approval for 2009 H1N1 flu test

The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced today that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration for emergency use of a new test to diagnose the 2009 H1N1 swine flu virus.

30 Oct 2009

Researchers report preclinical results of a novel PET biomarker designed to detect malignant breast tumors

Researchers at Thomas Jefferson University in Philadelphia, PA, supported in part by NuView Life Sciences, have published an article in the Journal of Nuclear Medicine reporting preclinical results of a novel PET biomarker designed to selectively detect malignant breast tumors.

30 Oct 2009

Research provides new insight on gene fusion, a phenomenon known to cause prostate cancer

Researchers at the University of Michigan Comprehensive Cancer Center have discovered what leads to two genes fusing together, a phenomenon that has been shown to cause prostate cancer to develop.

30 Oct 2009

Study: HSP inhibitor could stop tumor formation and extend survival

Like yoga for office drones, cells do have coping strategies for stress. Heat, lack of nutrients, oxygen radicals - all can wreak havoc on the delicate internal components of a cell, potentially damaging it beyond repair. Proteins called HSPs (heat shock proteins) allow cells to survive stress-induced damage. Scientists have long studied how HSPs work in order to harness their therapeutic potential.

30 Oct 2009

Fiscal 2009 results announced by Helix BioPharma

Helix BioPharma Corp. today announced financial results for the year ended July 31, 2009.

30 Oct 2009

UCLA Kaiser Permanente Center expands to eliminate health disparities

The UCLA School of Public Health has received a $5.2 million gift from Kaiser Permanente to endow the UCLA Kaiser Permanente Center for Health Equity. The center, formerly known as the Center to Eliminate Health Disparities, is dedicated to improving the health of underserved populations through research, community collaboration and leadership development.

30 Oct 2009

Researchers use BEZ235 drug to eliminate NSCL cancer

Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.

30 Oct 2009

Study shows how differing Asian cultures and attitudes impact cancer screening rates

The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander."

30 Oct 2009

PEM scanners outperform MRI in detecting breast cancer

An NIH-sponsored, multi-year study of hundreds of women diagnosed with breast cancer found that Positron Emission Mammography (PEM) scanners significantly outperform MRI when differentiating between benign and cancerous lesions.

30 Oct 2009

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

TomoTherapy Incorporated announced today that several clinical presentations at the American Society for Radiation Oncology's 51st ASTRO Annual Meeting -- November 1-5, 2009 in Chicago -- will showcase the use of the TomoTherapy® radiation therapy platform as a vital component in the combined modality approach to treating cancer.

30 Oct 2009

Human Genome Sciences declares financial results for third quarter 2009; reports increased revenue growth

Human Genome Sciences, Inc. today announced financial results for the quarter ended September 30, 2009, and provided highlights of recent key developments.

30 Oct 2009

Celera to use Medical Therapies' midkine patent portfolio for development of novel lung cancer diagnostics

Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY’s midkine patent portfolio for the development of novel lung cancer diagnostics.

30 Oct 2009

USC to develop stem cell-based treatment for age-related macular degeneration with CIRM grant

Physician-researchers at the University of Southern California (USC) received a nearly $16 million grant from the California Institute of Regenerative Medicine (CIRM) to fund the development of a stem cell-based treatment for age-related macular degeneration, the leading cause of vision loss and blindness among the elderly.

29 Oct 2009

Positive results from Celldex Therapeutics' Phase 1 studies of CDX-1307 cancer vaccine candidate

Celldex Therapeutics, Inc. today announced positive results from Phase 1 studies of CDX-1307 in patients with advanced epithelial cancers, including breast, colon, bladder and pancreatic cancer.

29 Oct 2009

Phase Forward’s InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward’s InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.

29 Oct 2009

Cancer News and Research

Latest Cancer News and Research

New study reviews science behind the efficacy of biofield therapies on pain management

Hard to Treat Diseases negotiating possible merger with EU based stem cell research company

University of Virginia Cancer Center commences patient treatment with the TomoDirect delivery mode

Heidelberg Ion Radiation Therapy Center established; European patients can benefit from new radiation therapy

NIH awards $75 million to establish medical research consortium to combat health disparities

TGen to secure emergency FDA approval for 2009 H1N1 flu test

Researchers report preclinical results of a novel PET biomarker designed to detect malignant breast tumors

Research provides new insight on gene fusion, a phenomenon known to cause prostate cancer

Study: HSP inhibitor could stop tumor formation and extend survival

Fiscal 2009 results announced by Helix BioPharma

UCLA Kaiser Permanente Center expands to eliminate health disparities

Researchers use BEZ235 drug to eliminate NSCL cancer

Study shows how differing Asian cultures and attitudes impact cancer screening rates

PEM scanners outperform MRI in detecting breast cancer

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

Human Genome Sciences declares financial results for third quarter 2009; reports increased revenue growth

Celera to use Medical Therapies' midkine patent portfolio for development of novel lung cancer diagnostics

USC to develop stem cell-based treatment for age-related macular degeneration with CIRM grant

Positive results from Celldex Therapeutics' Phase 1 studies of CDX-1307 cancer vaccine candidate

Phase Forward’s InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Understanding the DNA Damage Response in Innate Immunity eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in